Furthermore, oncogenic miRNAs trigger CP resistance in NSCLC cells by targeting various pathways, such as Wnt/β-catenin, Rab6, CASP2, PTEN, and Apaf-1. The gene discussed is CP; the disease is non-small cell lung carcinoma.